Business

Announcement on CDE’s Technical Review of the Drug Substance Atorvastatin Calcium by the Holding Subsidiary

Announcement on CDE’s Technical Review of the Drug Substance Atorvastatin Calcium by the Holding Subsidiary

articleNingbo Menovo Pharmaceutical Co., Ltd. Class ADecember 18, 20253/news/announcement-on-cdes-technical-review-of-the-drug-substance-atorvastatin-calcium-by-the-holding-subsidiary
Announcement on CDE’s Technical Review of the Drug Substance Atorvastatin Calcium by the Holding Subsidiary

About this update from Ningbo Menovo Pharmaceutical Co., Ltd. Class A

Announcement on CDE’s Technical Review of the Drug Substance Atorvastatin Calcium by the Holding Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Ningbo Menovo Pharmaceutical Co., Ltd. Class A